11/5
07:30 am
rgen
Repligen Corporation to Present at Upcoming Investor Conferences
Medium
Report
Repligen Corporation to Present at Upcoming Investor Conferences
10/31
07:30 am
rgen
Repligen to Report Third Quarter 2024 Financial Results
Low
Report
Repligen to Report Third Quarter 2024 Financial Results
10/22
11:53 am
rgen
Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release [Yahoo! Finance]
Low
Report
Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release [Yahoo! Finance]
10/14
11:28 am
rgen
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More [Yahoo! Finance]
Low
Report
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More [Yahoo! Finance]
9/26
11:04 am
rgen
Repligen Co. (NASDAQ: RGEN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $205.00 price target on the stock.
Low
Report
Repligen Co. (NASDAQ: RGEN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $205.00 price target on the stock.
9/24
07:30 am
rgen
Repligen Opens Training & Innovation Center to Elevate Customer Experience
Low
Report
Repligen Opens Training & Innovation Center to Elevate Customer Experience
9/18
04:51 pm
rgen
Repligen financial statements require restatement due to revenue recognition error [Seeking Alpha]
Low
Report
Repligen financial statements require restatement due to revenue recognition error [Seeking Alpha]
9/11
06:49 am
rgen
Several Headwinds Dragged Repligen Corporation (RGEN) in Q2 [Yahoo! Finance]
Low
Report
Several Headwinds Dragged Repligen Corporation (RGEN) in Q2 [Yahoo! Finance]
9/9
05:48 am
rgen
Reasons for the Decline of Repligen (RGEN) in Q2 [Yahoo! Finance]
Low
Report
Reasons for the Decline of Repligen (RGEN) in Q2 [Yahoo! Finance]
9/7
07:45 am
rgen
Repligen Corporation (RGEN) Fell Due to CEO Transition [Yahoo! Finance]
Low
Report
Repligen Corporation (RGEN) Fell Due to CEO Transition [Yahoo! Finance]
8/29
12:52 pm
rgen
Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
8/29
08:08 am
rgen
Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Medium
Report
Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate [Yahoo! Finance]
8/27
06:30 pm
rgen
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $180.00 price target on the stock.
Low
Report
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $180.00 price target on the stock.
8/23
08:59 am
rgen
Repligen Corporation (RGEN) Benefitted From Drug Approval [Yahoo! Finance]
Low
Report
Repligen Corporation (RGEN) Benefitted From Drug Approval [Yahoo! Finance]
8/23
07:30 am
rgen
Repligen Corporation to Present at Wells Fargo Healthcare Conference
Low
Report
Repligen Corporation to Present at Wells Fargo Healthcare Conference
8/16
04:52 pm
rgen
Maravai LifeSciences may be worth $15 to $20 share in a takeout - analyst [Seeking Alpha]
Medium
Report
Maravai LifeSciences may be worth $15 to $20 share in a takeout - analyst [Seeking Alpha]
8/16
12:10 pm
rgen
Maravai LifeSciences jumps on report of Repligen takeover offer [Seeking Alpha]
Low
Report
Maravai LifeSciences jumps on report of Repligen takeover offer [Seeking Alpha]
8/16
04:44 am
rgen
Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)? [Yahoo! Finance]
Medium
Report
Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)? [Yahoo! Finance]